Penumbra Inc (PEN)
N/A x N/A 290.50 x 2
Post-market by (Cboe BZX)
262.28 -10.96 (-4.01%) 04/04/25 [NYSE]
N/A x N/A 290.50 x 2
Post-market 262.28 unch (unch) 16:01 ET
for Fri, Apr 4th, 2025
Results
download Want to compare other data? Select FieldsSymbol | PEN | HOLX | GMED | ||
Company | Penumbra Inc | Hologic Inc | Globus Medical Inc | ||
Price Information | |||||
Exchange | NYSE | NASDAQ | NYSE | ||
Open | 263.38 | 61.00 | 69.98 | ||
High | 267.47 | 63.00 | 70.28 | ||
Low | 255.00 | 60.37 | 67.52 | ||
Last | 262.28 | 60.86 | 68.83 | ||
Change | -10.96 | -0.83 | -3.19 | ||
% Change | -4.01% | -1.35% | -4.43% | ||
Volume | 576,800 | 6,509,000 | 2,057,700 | ||
20-Day Average Volume | 441,655 | 2,884,205 | 1,464,985 | ||
Previous Close | 273.24 | 61.69 | 72.02 | ||
Industry | Medical Instruments | Medical Instruments | Medical Instruments | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 272.30 | 61.63 | 73.09 | ||
20-Day Raw Stochastic | 22.84% | 24.19% | 13.83% | ||
20-Day Relative Strength | 44.70% | 41.26% | 34.75% | ||
Weighted Alpha | +24.04 | -26.46 | +12.03 | ||
Today's Opinion | 40% Buy | 100% Sell | 56% Sell | ||
Previous Opinion | 64% Buy | 100% Sell | 56% Sell | ||
Last Month's Opinion | 88% Buy | 100% Sell | 8% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -1.97% since 03/28/25 | -0.75% since 03/28/25 | -5.13% since 03/28/25 | ||
Low | 255.00 on 04/04/25 | 59.06 on 04/03/25 | 67.52 on 04/04/25 | ||
High | 279.79 on 04/02/25 | 63.00 on 04/04/25 | 75.73 on 04/02/25 | ||
1-Month | |||||
%Chg | -7.52% since 03/04/25 | -2.31% since 03/04/25 | -11.84% since 03/04/25 | ||
Low | 254.50 on 03/11/25 | 59.06 on 04/03/25 | 67.52 on 04/04/25 | ||
High | 288.57 on 03/25/25 | 66.50 on 03/10/25 | 79.19 on 03/05/25 | ||
3-Month | |||||
%Chg | +8.39% since 01/03/25 | -16.85% since 01/03/25 | -16.86% since 01/03/25 | ||
Low | 222.59 on 01/06/25 | 59.06 on 04/03/25 | 67.52 on 04/04/25 | ||
High | 310.00 on 02/19/25 | 74.50 on 01/06/25 | 94.93 on 01/30/25 | ||
6-Month | |||||
%Chg | +34.69% since 10/04/24 | -24.15% since 10/04/24 | -2.59% since 10/04/24 | ||
Low | 190.08 on 10/07/24 | 59.06 on 04/03/25 | 67.52 on 04/04/25 | ||
High | 310.00 on 02/19/25 | 84.39 on 11/04/24 | 94.93 on 01/30/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 10,101,974 | 13,656,375 | 9,467,017 | ||
Shares Outstanding, K | 38,516 | 224,390 | 137,542 | ||
Annual Sales | 1,194,620,000 | 4,030,300,000 | 2,519,360,000 | ||
Annual Net Income | 14,010,000 | 789,500,000 | 102,980,000 | ||
Last Quarter Sales | 315,520,000 | 1,021,800,000 | 657,290,000 | ||
Last Quarter Net Income | 33,680,000 | 201,000,000 | 26,510,000 | ||
60-Month Beta | 0.56 | 0.82 | 1.28 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.97 on 02/18/25 | 1.03 on 02/05/25 | 0.84 on 02/20/25 | ||
Latest Earnings Date | 04/23/25 | 05/01/25 | 05/06/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 95.21 | 14.94 | 22.94 |